Wed, Apr 23, 2014, 3:48 AM EDT - U.S. Markets open in 5 hrs 42 mins


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

troublesacomin 35 posts  |  Last Activity: Apr 14, 2014 9:26 PM Member since: May 16, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • here within the week or so. Just a hunch, sorry no facts. But its about time, they need to get this out of the way so the stock can start rebounding.

  • I wonder wonder wonder.

  • Reply to

    short game over, stock has bottomed

    by hope_is_for_suckers Apr 9, 2014 4:45 PM
    troublesacomin troublesacomin Apr 10, 2014 8:15 AM Flag

    Nobody cares about some tests months away, where is management on all of these claims? Kriegsman as the great Oz, "Pay no attention to those lawsuits and possible SEC investigation" and where is CYTR management when they caused this crisis? Nowhere, you can talk about this or that all you want but where is management on these lawsuits because i think they've done enough promoting this one drug.

  • troublesacomin by troublesacomin Apr 10, 2014 5:05 AM Flag

    PBR will be back over $20 in 1 year.

    This would go a lot quicker if the Brazilians woke up and saw their little "ideal" social programs aren't working.

  • Reply to


    by asicprof Apr 9, 2014 2:00 AM
    troublesacomin troublesacomin Apr 9, 2014 3:11 AM Flag

    “Stock may trade to north of $15 if Aldo gets BTD. A monster run may start in the beginning of June as GBM P2 enrollment completes.” You don’t know how this stock trades on news.

    “We think that Aldo will shows efficacy and GBM and FDA will grant BTD (Break through designation) to Aldo.” Part of the results from those shady countries are in question. A lot of us always questioned why the ceo and management went off on “trips” to Europe on investor dollars.

    “CYTR is the life time opportunity if one has stomach to hold the stock for 1 year. “ Sounds like more promoter bs. I’ve held this for nearly 2 years and its not for beginner investors looking for a quick buck, relying on outside articles. Just ask the people that believed in the hype in the summer of 2012 when it was something like $4-5 then crashed to nearly $1.50 in November or people that recently jumped on the bandwagon.

    “Out research team reviewed all the articles from Dream Team”. If you are relying on articles then you shouldn’t be in this stock. Do your own work.

    “Recent short attack was meticulously planed to shake out trader , and weak hand who bought stock with margin account . This is typical bio-tech phenomena.” More promotion nonsense. This stock has fundamental problems namely its management sucking money from investors and what looks to be some shady dealings that the SEC needs to investigate.

    “we found that all the information in the articles is consistent of with our bullish view”. How about a balanced view? If you’re promoting this stock, you’re either a short in wolves clothing or a fool.

  • Reply to

    Come on.....where's all the shorts? Too quiet.

    by pendlorian Apr 1, 2014 5:34 PM
    troublesacomin troublesacomin Apr 2, 2014 12:03 AM Flag

    I gave an honest opinion of what to look out for. You can do whatever you want with it since i clearly have no idea about this stock.

  • Reply to

    Come on.....where's all the shorts? Too quiet.

    by pendlorian Apr 1, 2014 5:34 PM
    troublesacomin troublesacomin Apr 1, 2014 8:05 PM Flag

    You have absolutely nothing to fear but the outcome of the upcoming trials, current lawsuits and the possibility of an SEC investigation notice. But besides those small problems you have management that is paying itself rates for managing a large company when CYTR is still a microcap and is kinda shady shown by these recent events but besides that, your investment in CYTR looks good. Congrats. Ooh and CYTR’s pipeline is basically ONE drug. I'm not up to date on the status of those platinum linkers but they were far away from serious trials but besides those small problems, everything looks good to go.

    I’m not short and really couldn’t care what happens to the company because I sold most of my $1.65 shares of CYTR. I’m holding a very very small amount of shares but you people with these posts are just looking at CYTR whether its up or down one day and not looking at the whole picture.

    And the majority of you are not CYTR longs by choice but circumstance. You are retail traders that believed biased hype and should be looking at this company’s fundamentals instead of posting on message boards or reading the opinions of bio analysts.

  • Reply to

    Went green today and took advantage, sold out.

    by cdmurray4 Mar 28, 2014 3:31 PM
    troublesacomin troublesacomin Mar 28, 2014 10:07 PM Flag

    This murray is a retail investor that doesn’t know when to properly enter or exit a stock.

    By looking at this post, they also bought too much of an asset compromising their total portfolio and also bought too much of the asset at certain levels without leaving enough money to take advantage of downward movements.

    The reasons for getting out of this asset shows the investor does not know enough in the individual asset also.

    Notice I’m not saying anything about the asset but the thought process of the original poster.

  • Reply to

    Partnership rumors...

    by me_the_actuary Mar 28, 2014 3:39 PM
    troublesacomin troublesacomin Mar 28, 2014 6:58 PM Flag

    Just shows there is still too many retail investors that do not know the products, management or whats going on.

  • troublesacomin by troublesacomin Mar 27, 2014 10:01 AM Flag

    “We believe the recent lawsuits and negative publicity are without merit, and we intend to defend ourselves vigorously against all claims, but not through the press."

    How much of company funds will be used to defend themselves?

    Gotta love that CYTR management to put themselves in such a position.

  • Reply to


    by phantomtrader75 Mar 25, 2014 11:15 PM
    troublesacomin troublesacomin Mar 26, 2014 2:19 AM Flag

    There are fundamental reasons why this stock has fallen from over $100 a share just a few years ago to 7 and change today.

    Contrarian investing might work here but its still early. Even at these levels WLT could go much lower because of its financial problems and the lowered demand for coal. Everyone has heard that Nucor has switched to nat gas from coal. Politicians are against coal from making a big comeback because of environmental concerns. I haven’t checked how much WLT exports but the recent HSBC PMI data was weak so China more than likely will be slowing down and also hamper coal demand.

    You are fighting a downward trend and have no idea how low it can go, not the best way to invest. I’m watching but not buying WLT and I would wait for some type of stability in the stock. You also need to wait for institutional big money to change their views on the industry and start buying coal stocks up, until then you're fighting the trend and have to ride it out the violent price swings. I would start listening more to the analysts who recommend where institutional investors place their money.

  • Reply to

    S[ecal May 9, 2014 meeting - dilute shares?

    by stcksnmore Mar 18, 2014 1:44 PM
    troublesacomin troublesacomin Mar 22, 2014 5:37 PM Flag

    That's part of the proxy and is accurate, you are behind the story.

    Yahoo has not updated its SEC filings for BKCC yet. Go to the Nasdaq site, look up BKCC and look at SEC filings on the right side and get caught up. BKCC just filed an 8c on the proposed offering on Friday.

    If you can't find the BKCC's SEC filings how in the world do you know what you're buying?

    I'm a potential buyer of BKCC shares but you seem lost.

  • on world events like what Russia is doing when shareholders of CBLI should be focusing on development of leading CBLI drug candidate and looking at CBLI’s balance sheet for funding but then I just yawn and go back to looking at other company SEC filings and listening to conference calls.

    Just another day, I don’t get too excited on up days or down days.

  • Reply to

    Smith on Stocks

    by value_huntin Mar 19, 2014 1:19 PM
    troublesacomin troublesacomin Mar 19, 2014 1:42 PM Flag

    $1.50 when NWBO reports results, whenever that is?

    Just remember it was Smith that set retail investors up for all this hype concerning NWBO without mentioning the drawbacks. Been waiting nearly 2 years for this nonsense concerning Smith and NWBO to end. Can't wait.

    NWBO shareholders with more than 100K in losses please contact . . . lolololol coming.

    I have zero interest in NWBO but hate how Smith has only giving one side of the story.

  • Reply to

    Active trading this morning....

    by brchad Mar 19, 2014 11:31 AM
    troublesacomin troublesacomin Mar 19, 2014 12:20 PM Flag

    Someone disagrees with Mr Zito's a few weeks late from that last reporting quarter and definitely a few bucks short opinion on this stock.

    Just take it in stride, don't get too excited one way or the other. This company moved big time from the high end of the range to the bottom in 2012, this isn't new.

    The next quarter will give shareholders a better idea of what's going on with this company.

  • Reply to

    DOD ordered 40,000 doses September 2010!

    by snowboard2k01 Mar 19, 2014 9:36 AM
    troublesacomin troublesacomin Mar 19, 2014 11:08 AM Flag

    Too bad this is March 2014. the story has changed.

    Find out what upcoming catalysts CBLI has and try your best to weigh the pros/cons of the CBLI story and take a small speculative position in it to see if it pays off. 2010? ugh.

  • troublesacomin troublesacomin Mar 19, 2014 10:49 AM Flag

    Is there any poster on this BOARD that understands an SEC investigation notice?

  • It fell big time off downward momentum from that recent big payout. If the markets don't get killed this week I'd say by early next week back to 14 but if markets get #$%$, we'll be sitting here awhile.

  • troublesacomin troublesacomin Mar 16, 2014 2:26 PM Flag

    Good to get upset but I would focus on all the mistakes YOU made in this trade and not focus on other things out of your control like lawsuits or articles or other people's opinions.

    As for NWBO, from what I know, Larry Smith is a not a stock promoter working for another company or something but gives only the positive side of his stock investments without hinting at the negatives which set giddy retail investor who depend on such sites as Seeking Alpha and TheStreet up for failure.

    If someone like me can tell when NWBO is going to do an offering then a few weeks later does it and Larry Smith who actively follows the stock is silent on the matter, something is very, very wrong. The guy can write page after page of how wonderful a stock of his is and doesn’t give the obvious problems of the asset. But that’s kinda what a retail investor wants, they want how wonderful something is and not look at the downside of an asset so Larry is doing a wonderful job at appealing to misinformed investors. Only when its too late do they pay attention to that side of the trade.

    Nor can I support Adam Feuerstein because one aspect of his job at the TheStreet is to shoot down stocks that he sees as too risky for retail investors and he’s also been known to be wrong!!! Both Adam, Larry and the majority of these so called biotech gurus that retail investors follow aren’t going to give investors the full story anyway. In order to get that, you’ll have to do that work yourself.

    But overall, the more you know about the asset, the less you’re concerned about what people like Adam or Larry are saying. You should be able to make money off their input if you have some experience in biotech, portfolio management and can execute a trade properly. So learn from the experience, don’t blame others for YOUR decision to sell for a loss because you put yourself in a position where you felt the need to sell.

  • Reply to

    Advice on Buying Options

    by jasonsglb Mar 10, 2014 8:41 PM
    troublesacomin troublesacomin Mar 11, 2014 3:22 AM Flag

    no no and no.

    you have to wait and see how low this goes 1st off. i thought 4.75 when it was 6.50 and said why. now it looks like $4 and you don't have any catalysts to move the stock until the end of the year.

    if you want to buy options wait for the Jan15 calls trade.

1.25+0.06(+5.04%)Apr 22 4:01 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Allergan Inc.
NYSETue, Apr 22, 2014 4:00 PM EDT
Weibo Corporation
NasdaqGSTue, Apr 22, 2014 4:00 PM EDT
GW Pharmaceuticals plc
NasdaqGMTue, Apr 22, 2014 4:00 PM EDT